// App-Quantinova.ai

FRI0286 : IXEKIZUMAB TREATMENT IMPROVES FATIGUE, SPINAL PAIN, STIFFNESS, AND SLEEP IN PATIENTS WITH NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS

Researchers

Presenter

  • P. J. Mease

Principal Investigators

  • A. Deodhar

  • P. Rahman

  • H. Marzo-Ortega

  • V. Strand

  • T. Hunter

  • D. Adams

  • D. Sandoval

  • A. Kronbergs

  • B. Zhu

  • A. Leung

  • S. Liu Leage

  • V. Navarro-Compn

Medical Centers

  • Swedish Medical Center/Providence St. Joseph Health, Seattle, United States of America

  • Oregon Health and Science University, Rheumatology Clinica Division of Arthritis and Rheumatic Diseases, Portland, United States of America

  • Memorial University of Newfoundland, Department of Rheumatology, St. John’s, Canada

  • University of Leeds, NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals Trust, and Leeds Institute of Rheumatic and Musculoskeletal Medicine, Leeds, United Kingdom

  • Stanford, Division of Immunology and Rheumatology, Stanford, United States of America

  • Eli Lilly and Company, Indianapolis, United States of America

  • Syneos Health, Morrisville, NC, United States of America

  • Hospital Universitario La Paz, Madrid, Spain

Locations

  • United States

  • Canada

  • United Kingdom

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Musculoskeletal

Disease

  • Non-radiographic axial spondyloarthritis

  • Axial spondyloarthritis

Biomarkers

  • N/A

Drug/Treatment

  • LY2439821

Outcome

  • N/A


Study Design

  • Randomized

  • Double Blind/Blinded

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Abbvie

Result

  • N/A